Tejara Capital’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Tejara Capital’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-110,000	Closed	-$462K	–	96
2023 Q1	$462K	Buy	+110,000	New	+$571K	0.24%	63

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Tejara Capital's CTIC Position: Q2 2023 in Review

Tejara Capital sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 110,000 shares — an estimated $462K sold.

Tejara Capital first reported a position in CTIC in Q1 2023 and held it in 1 quarter. The position peaked at $462K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Tejara Capital reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Tejara Capital sold 110,000 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $462K.
Tejara Capital first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2023 and held it in 1 quarter.
Tejara Capital's CTI BioPharma Corp. (DE) Common Stock position peaked at $462K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Tejara Capital's 13F filing for Q2 2023, filed 11 Aug 2023.